Forteo to remain Decision Resources' proprietary clinical gold standard for treatment of osteoporosis

Links shared publicly online about this topic.

1,337
total visits

Forteo to remain Decision Resources' proprietary clinical gold standard for treatment of osteoporosis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.

View full resource at news-medical.net

Tags: Fracture, Osteoporosis, Osteoporosis Medication, Drug, Healthcare, Pharma, Forteo, Physician